Authors: Prevost, GP Pradines, A Brezak, MC Lonchampt, MO Viossat, I Ader, I Toulas, C Kasprzyk, P Gordon, T Favre, G Morgan, B

Citation: Gp. Prevost et al., Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228, INT J CANC, 91(5), 2001, pp. 718-722

Authors: Baron, R Fourcade, E Lajoie-Mazenc, I Allal, C Couderc, B Barbaras, R Favre, G Faye, JC Pradines, A

Citation: R. Baron et al., RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: Evidenced in vivo by an anti-farnesyl cysteine antibody, P NAS US, 97(21), 2000, pp. 11626-11631

Authors: Allal, C Favre, G Couderc, B Salicio, S Sixou, S Hamilton, AD Sebti, SM Lajoie-Mazenc, I Pradines, A

Citation: C. Allal et al., RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription, J BIOL CHEM, 275(40), 2000, pp. 31001-31008

Authors: Chen, Z Sun, JZ Pradines, A Favre, G Adnane, J Sebti, SM

Citation: Z. Chen et al., Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice, J BIOL CHEM, 275(24), 2000, pp. 17974-17978

Authors: Prevost, GP Pradines, A Viossat, I Brezak, MC Miquel, K Lonchampt, MO Kasprzyk, P Favre, G Pignol, B Le Breton, C Dong, J Morgan, B

Citation: Gp. Prevost et al., Inhibition of human tumor cell growth in vitro and in vivo by a specific inhibitor of human farnesyltransferase: BIM-46068, INT J CANC, 83(2), 1999, pp. 283-287

Authors: Asslan, R Pradines, A Pratx, C Allal, C Favre, G Le Gaillard, F

Citation: R. Asslan et al., Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells, BIOC BIOP R, 260(3), 1999, pp. 699-706